With the corporate mission of "relieving patients suffering from pain and bringing comfort to their daily lives," we are developing novel small-molecule drugs for the treatment of peripheral neuropathic pain. Rather than merely providing symptomatic relief, our goal is to create curative therapies that address the root cause of the condition, thereby resolving unmet medical needs in this field.